The import of heterocyclic compounds with an unfused imidazole ring into the UK is poised for a downward trend from 2024 to 2028, with values dropping from $151.75 million in 2024 to $101.01 million in 2028. This forecast marks a consistent decrease in import value with an overall compound annual growth rate (CAGR) of negative two figures over the forecasted period. In 2023, the import value was approximately 4% higher than in 2024, indicating the beginning of a declining trend which intensifies over the years.

Future trends to watch for:

Changes in global demand and supply dynamics for heterocyclic compounds.
Potential regulatory adjustments impacting chemical imports in the UK.
Technological advancements in domestic production that may reduce reliance on imports.